NCT02244203View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

BI 60732

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY